Residual Renal Function in Hemodialysis Patients: The Role of Angiotensin-Converting Enzyme Inhibitor in Its Preservation

Table 4

Results.

Months	RRF-GFR (mL/min/1.73 m^2)		𝑃	Urine volume (mL)/24 h		𝑃
	Enalapril group	Control group		Enalapril group	Control group
0	8.1±2.1	8.0±2.0	n.s.	1630±320	1695±340	n.s.
3	6.9±1.5	7.5±1.6	n.s.	1415±300	1350±310	n.s.
6	6.4±1.4	6.1±1.4	n.s.	1360±290	1050±305	<0.05
9	5.4±1.6	3.6±1.6	<0.05	1210±255	720±180	<0.05
12	2.9±1.2	1.1±0.5	<0.05	690±270	330±160	<0.05